Literature DB >> 33336901

Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.

Yazdan Mokhtari1, Atieh Pourbagheri-Sigaroodi1, Parisa Zafari2,3, Nader Bagheri4, Seyed H Ghaffari5, Davood Bashash1.   

Abstract

In the dark path of tumorigenesis, the more carefully the cancer biology is studied, the more brilliant answers could be given to the countless questions about its orchestrating derivers. The identification of the correlation between Toll-like receptors (TLRs) and different processes involved in carcinogenesis was one of the single points of blinding light highlighting the interconnection between the immune system and cancer. TLRs are a wide family of single-pass membrane-spanning receptors that have developed through the evolution to recognize the structurally conserved molecules derived from microorganisms or damaged cells. But this is not everything about these receptors as they could orchestrate several downstream signalling pathways leading to the formation or suppression of cancer cells. The present review is tempted to provide a concise schematic about the biology and the characters of TLRs and also summarize the major findings of the regulatory role of TLRs and their associated signalling in the pathogenesis of human cancers.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  Toll-like receptor (TLR); cancer; immune system; inflammation; pattern-recognition receptor

Mesh:

Substances:

Year:  2020        PMID: 33336901      PMCID: PMC7812258          DOI: 10.1111/jcmm.16214

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  95 in total

1.  Toll to be paid at the gateway to the vessel wall.

Authors:  Göran K Hansson; Kristina Edfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06       Impact factor: 8.311

2.  Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response.

Authors:  Hui-Ching Chuang; Hung-Yu Lin; Pei-Lin Liao; Chao-Cheng Huang; Li-Ling Lin; Wen-Ming Hsu; Jiin-Haur Chuang
Journal:  Lab Invest       Date:  2019-12-19       Impact factor: 5.662

3.  Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.

Authors:  Bahareh Kashani; Zahra Zandi; Mohammad Reza Karimzadeh; Davood Bashash; Ali Nasrollahzadeh; Seyed H Ghaffari
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

4.  A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.

Authors:  Takashi Kiyokawa; Sachiko Akashi-Takamura; Takuma Shibata; Fumi Matsumoto; Chiaki Nishitani; Yoshio Kuroki; Yasuyuki Seto; Kensuke Miyake
Journal:  Int Immunol       Date:  2008-09-09       Impact factor: 4.823

Review 5.  The Yin and Yang of Toll-like receptors in cancer.

Authors:  J-P Pradere; D H Dapito; R F Schwabe
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

6.  Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer.

Authors:  Taweesak Tongtawee; Theeraya Simawaranon; Wareeporn Wattanawongdon; Chavaboon Dechsukhum; Wilairat Leeanansaksiri
Journal:  Turk J Gastroenterol       Date:  2019-01       Impact factor: 1.852

7.  Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

Authors:  Masayuki Fukata; Anli Chen; Arunan S Vamadevan; Jason Cohen; Keith Breglio; Suneeta Krishnareddy; David Hsu; Ruliang Xu; Noam Harpaz; Andrew J Dannenberg; Kotha Subbaramaiah; Harry S Cooper; Steven H Itzkowitz; Maria T Abreu
Journal:  Gastroenterology       Date:  2007-09-14       Impact factor: 22.682

8.  Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin.

Authors:  Cevayir Coban; Ken J Ishii; Taro Kawai; Hiroaki Hemmi; Shintaro Sato; Satoshi Uematsu; Masahiro Yamamoto; Osamu Takeuchi; Sawako Itagaki; Nirbhay Kumar; Toshihiro Horii; Shizuo Akira
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

9.  The immunostimulatory effects and pro-apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll-like receptor 4.

Authors:  Jinju Yang; Hongwei Zhang; Ziwei Zhu; Yadan Gao; Benqiong Xiang; Qun Wei
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

Review 10.  Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.

Authors:  Yazdan Mokhtari; Atieh Pourbagheri-Sigaroodi; Parisa Zafari; Nader Bagheri; Seyed H Ghaffari; Davood Bashash
Journal:  J Cell Mol Med       Date:  2020-12-18       Impact factor: 5.295

View more
  8 in total

Review 1.  The role of the inflammasome and its related pathways in ovarian cancer.

Authors:  Chenxi Liu; Xuemei Huang; Hongling Su
Journal:  Clin Transl Oncol       Date:  2022-03-14       Impact factor: 3.340

2.  The Anti-Apoptotic Role of COX-2 during In Vitro Infection of Human Intestinal Cell Line by Giardia duodenalis and the Potential Regulators.

Authors:  Yongwu Yang; Yudan Zhao; Lin Liu; Weining Zhu; Shuo Jia; Xiaoyun Li; Wei Li
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

Review 3.  Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease.

Authors:  Wenbin Dai; Longhai Long; Xiaoqiang Wang; Sen Li; Houping Xu
Journal:  Chin Med       Date:  2022-04-28       Impact factor: 4.546

Review 4.  Probiotics and Trained Immunity.

Authors:  Naima G Cortes-Perez; Alejandra de Moreno de LeBlanc; Jorge G Gomez-Gutierrez; Jean Guy LeBlanc; Luis G Bermúdez-Humarán
Journal:  Biomolecules       Date:  2021-09-24

5.  Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity.

Authors:  Sumei Ren; Xiaodong Wang; Guangyi Jin
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 6.  Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer.

Authors:  John Gubatan; Theresa Louise Boye; Michelle Temby; Raoul S Sojwal; Derek R Holman; Sidhartha R Sinha; Stephan R Rogalla; Ole Haagen Nielsen
Journal:  Microorganisms       Date:  2022-07-07

Review 7.  Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.

Authors:  Yazdan Mokhtari; Atieh Pourbagheri-Sigaroodi; Parisa Zafari; Nader Bagheri; Seyed H Ghaffari; Davood Bashash
Journal:  J Cell Mol Med       Date:  2020-12-18       Impact factor: 5.295

Review 8.  TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.

Authors:  Jie Guo; Mengfan Liao; Jun Wang
Journal:  Cell Commun Signal       Date:  2021-09-03       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.